« Back to Record
Roy, D. C., Walker, I., Maertens, J., Lewalle, P., Olavarria, E., Selleslag, D., Lachance, S., Buyse, M., Wang, K., Rovers, J., Santi, I., Bonig, H., Sandler, A., Velthuis, J. H. L., & Mielke, S. (2020). ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia. Leukemia. doi:10.1038/s41375-020-0733-0
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/305065



